Arete Wealth Advisors LLC purchased a new position in shares of The Clorox Company (NYSE:CLX – Free Report) in the first quarter, according to its most recent filing with the SEC. The firm purchased 5,027 shares of the company’s stock, valued at approximately $795,000.
A number of other large investors have also recently bought and sold shares of the business. Vanguard Group Inc. grew its holdings in Clorox by 1.3% during the 1st quarter. Vanguard Group Inc. now owns 14,685,046 shares of the company’s stock worth $2,041,661,000 after acquiring an additional 185,012 shares during the period. BlackRock Inc. grew its holdings in Clorox by 2.1% during the 1st quarter. BlackRock Inc. now owns 9,463,011 shares of the company’s stock worth $1,497,427,000 after acquiring an additional 195,348 shares during the period. Geode Capital Management LLC grew its holdings in Clorox by 3.8% during the 1st quarter. Geode Capital Management LLC now owns 2,725,410 shares of the company’s stock worth $430,349,000 after acquiring an additional 100,920 shares during the period. Stifel Financial Corp grew its stake in shares of Clorox by 5.1% in the 1st quarter. Stifel Financial Corp now owns 2,583,847 shares of the company’s stock valued at $408,878,000 after buying an additional 124,644 shares during the period. Finally, Northern Trust Corp grew its stake in shares of Clorox by 1.1% in the 1st quarter. Northern Trust Corp now owns 1,931,351 shares of the company’s stock valued at $268,515,000 after buying an additional 21,058 shares during the period. 77.98% of the stock is currently owned by institutional investors and hedge funds.
Clorox Price Performance
Clorox stock opened at $146.20 on Friday. The Clorox Company has a 52 week low of $124.58 and a 52 week high of $178.21. The company’s 50 day moving average price is $155.33 and its two-hundred day moving average price is $157.95. The company has a quick ratio of 0.59, a current ratio of 0.95 and a debt-to-equity ratio of 6.38. The stock has a market cap of $18.10 billion, a P/E ratio of 122.86, a P/E/G ratio of 2.13 and a beta of 0.28.
Clorox Increases Dividend
The business also recently declared a quarterly dividend, which was paid on Friday, August 25th. Investors of record on Wednesday, August 9th were issued a $1.20 dividend. This represents a $4.80 dividend on an annualized basis and a dividend yield of 3.28%. The ex-dividend date of this dividend was Tuesday, August 8th. This is a boost from Clorox’s previous quarterly dividend of $1.18. Clorox’s payout ratio is 403.36%.
Wall Street Analyst Weigh In
CLX has been the subject of several research reports. DA Davidson raised their target price on Clorox from $155.00 to $176.00 and gave the company a “neutral” rating in a research note on Monday, August 7th. Atlantic Securities upgraded Clorox from an “underweight” rating to a “neutral” rating in a research note on Thursday, August 3rd. Barclays raised their target price on Clorox from $117.00 to $127.00 and gave the company an “underweight” rating in a research note on Friday, August 4th. Finally, StockNews.com upgraded Clorox from a “hold” rating to a “buy” rating in a research note on Friday, September 8th. Six equities research analysts have rated the stock with a sell rating, six have assigned a hold rating and two have issued a buy rating to the company. According to MarketBeat, Clorox currently has a consensus rating of “Hold” and an average target price of $150.38.
Check Out Our Latest Stock Analysis on CLX
Insider Buying and Selling
In related news, CFO Kevin B. Jacobsen sold 3,346 shares of Clorox stock in a transaction that occurred on Monday, August 14th. The shares were sold at an average price of $160.82, for a total value of $538,103.72. Following the sale, the chief financial officer now owns 23,224 shares of the company’s stock, valued at approximately $3,734,883.68. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website. 0.41% of the stock is currently owned by insiders.
Clorox Profile
The Clorox Company manufactures and markets consumer and professional products worldwide. It operates through four segments: Health and Wellness, Household, Lifestyle, and International. The Health and Wellness segment offers cleaning products, such as laundry additives and home care products primarily under the Clorox, Clorox2, Scentiva, Pine-Sol, Liquid-Plumr, Tilex, and Formula 409 brands; professional cleaning and disinfecting products under the CloroxPro and Clorox Healthcare brands; professional food service products under the Hidden Valley brand; and vitamins, minerals and supplement products under the RenewLife, Natural Vitality, NeoCell, and Rainbow Light brands in the United States.
Featured Articles
- Five stocks we like better than Clorox
- Trading Stocks: RSI and Why it’s Useful
- China’s Jump In Car Sales Is Drawing Big Money To These Stocks
- How to Know if a Stock Pays Dividends and When They Are Paid Out
- 3 Reasons Price Weakness Is a Buying Opportunity For Lennar
- Financial Services Stocks Investing
- Name A Better Trio Than These Underrated High Potential Stocks
Want to see what other hedge funds are holding CLX? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for The Clorox Company (NYSE:CLX – Free Report).
Receive News & Ratings for Clorox Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Clorox and related companies with MarketBeat.com's FREE daily email newsletter.
